CVT 0.00% $1.12 comvita limited ordinary shares

Ann: GENERAL: CVT: Comvita Will Announce Half-Year Results, 12 November 2014

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. lightbulb Created with Sketch. 2
    • Release Date: 06/11/14 11:54
    • Summary: GENERAL: CVT: Comvita Will Announce Half-Year Results, 12 November 2014
    • Price Sensitive: No
    • Download Document  2.43KB
    					CVT
    06/11/2014 11:54
    GENERAL
    
    REL: 1154 HRS Comvita Limited
    
    GENERAL: CVT: Comvita Will Announce Half-Year Results, 12 November 2014
    
    On Wednesday 12 November, Comvita limited (CVT) will release its results
    announcement for the half-year ended 30 September 2014.
    
    Chairman Neil Craig and Comvita Chief Executive Brett Hewlett will host a
    conference call for investors and media to discuss these results.
    
    Dial-in details and the confirmation code are listed below:
    
    Date: Wednesday 12 November, 2014
    Time: 10:30am (NZST)
    Attendee dial-in (New Zealand Toll free): 0800 450 585
    Confirmation Code: 3012150
    
    International dial-in numbers for specific toll free country access:
    Australia 1 800 554 798
    UK 0808 234 8407
    Hong Kong 800 901 587
    China 4001 935 569
    Taiwan 00801 851 601
    South Korea 00798 613 60978
    Singapore 800 616 3105
    Malaysia 1 800 812 876
    
    Confirmation Code: 3012150
    
    # Ends #
    
    For further information:
    Comvita CEO, Brett Hewlett, 021 740 160
    Comvita Chairman, Neil Craig, 021 731 509
    Julie Chadwick, Comvita Communications Manager, 021 510 693
    
    Background information
    About Comvita (www.comvita.com)
    Comvita (NZX:CVT) is a global natural health company committed to the
    development of innovative products, backed by ongoing investment in
    scientific research. We are the world leaders in Manuka (leptospermum) honey
    and fresh-picked Olive Leaf Extract, which are at the core of the Comvita
    product range.
    
    We have approximately 50% of honey supply under direct ownership or control,
    with the balance of supply from long term contractual and partnership
    arrangements. Comvita pioneered the development and use of medical grade
    Manuka honey and was the first to receive FDA approval (2007). We partner
    with US wound care company Derma Sciences, Inc. (NASDAQ:DSCI), the global
    licensee for Medihoney specialist wound care products, which are used in
    hospitals and medical centres around the world. Comvita's freshly picked
    Olive Leaf Extract is grown, harvested, extracted and bottled at the world's
    largest specialised olive leaf grove, with over one million olive trees.
    
    Comvita sells into more than 18 countries through a network of our own
    branded retail locations, online (nine country specific e-commerce websites)
    and third-party outlets. We have over 450 staff located in New Zealand,
    Australia, Hong Kong, Japan, Taiwan, South Korea, the United Kingdom and the
    USA.
    
    Download the Comvita Investor App
    End CA:00257325 For:CVT    Type:GENERAL    Time:2014-11-06 11:54:12
    				
 
watchlist Created with Sketch. Add CVT (NZSX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.